Wilson Sonsini and Honigman advised Prime Medicine on the deal, while Davis Polk advised the joint book-running managers. Prime Medicine, Inc., a biotechnology company committed to...
Prime Medicine’s $175 Million IPO
VectivBio’s $125 Million Shares Offering
Latham & Watkins represented the underwriters in the offering. Homburger advised VectivBio. VectivBio Holding AG (Nasdaq: VECT) has announced the pricing of an underwritten offering of 16,700,000...
Immatics’ $110 Million Shares Offering
Davis Polk advised Immatics on the offering while Covington represented underwriters. Immatics N.V. executed its $110 million SEC-registered offering of ordinary shares. The ordinary shares are...
EDAP TMS’s $23 Million Follow-on Offering
Davis Polk represented Jefferies LLC, the sole book-running manager, in the offering. EDAP TMS S.A. executed $23 million public offering of 3,066,667 American Depositary Shares (which includes...
Allakos’ $150 Million Shares Offering
Davis Polk advised the representatives of the underwriters in the offering. Allakos Inc. announced its offering of 29,882,000 shares of common stock, for total gross proceeds of...
IDEAYA Biosciences’ $80 Million Common Stock Offering
Latham & Watkins represented IDEAYA, while Davis Polk advised the representatives of the several underwriters in the offering. IDEAYA Biosciences, Inc. (Nasdaq: IDYA) announced the pricing of an...
First Watch Restaurant’s Secondary Public Offering
Latham & Watkins represented the underwriters in the offering. First Watch Restaurant Group, Inc. (NASDAQ: FWRG), the Daytime Dining concept serving breakfast, brunch and lunch, has...
Immunocore’s $250 Million At-The-Market Offering
Davis Polk advised Jefferies, the sales agent, in the offering. Immunocore Holdings plc announced the SEC-registered at-the-marketing offering program of its American depositary shares (ADSs) representing its ordinary...
Portillo’s $218.5 Million Common Stock Offering
Latham & Watkins represented the underwriters in the offering. Portillo’s Inc. (Nasdaq: PTLO), the fast-casual restaurant concept known for its menu of Chicago-style favorites, closed on...
Vaccitech’s $75 Million At-The-Market Offering
Davis Polk advised the sales agent Jefferies in the offering. Vaccitech plc executed an at-the-marketing offering program of its American depositary shares representing its ordinary shares under...
Infinera’s $373.75 Million Convertible Senior Notes Offering
Davis Polk advised Jefferies, the sole book-running manager, in the offering. Infinera Corporation executed its offering of $373.75 million aggregate principal amount of 3.75% convertible senior...
Legend Biotech’s $403 Million Shares Offering
Davis Polk advised the underwriters in the offering while Jones Day advised GenScript Biotech Corporation. Legend Biotech Corporation executed its $403 million SEC-registered follow-on offering of 9,361,000...